ASIS for Botox in Chronic Migraine
Public ClinicalTrials.gov record NCT02074163. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT02074163
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- ASIS Corporation
- Industry
- Enrollment
- 60 participants
Conditions and interventions
Interventions
- Adverse Reactions of Botox intramuscularly Drug
- Adverse Reactions of Botox subdermally Drug
- Efficacy of Botox intramuscularly at Week 12 Drug
- Efficacy of Botox intramuscularly at Week 18 Drug
- Efficacy of Botox intramuscularly at Week 24, Drug
- Efficacy of Botox intramuscularly at Week 30 Drug
- Efficacy of Botox intramuscularly at Week 6 Drug
- Efficacy of Botox subdermally at Week 12 Drug
- Efficacy of Botox subdermally at Week 18 Drug
- Efficacy of Botox subdermally at Week 24 Drug
- Efficacy of Botox subdermally at Week 30 Drug
- Efficacy of Botox subdermally at Week 6 Drug
- Gadolinium Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2015
- Primary completion
- May 31, 2016
- Completion
- May 31, 2017
- Last update posted
- Jun 23, 2015
2016 – 2017
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Automatic Subdermal Injector System, Inc | Westminster | California | 92683 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02074163, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 23, 2015 · Synced May 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02074163 live on ClinicalTrials.gov.